Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhage

19 Feb 2008

Abstract excerpt

BACKGROUND: A patent ductus arteriosus (PDA) in preterm infants is associated with increased risk of intraventricular haemorrhage (IVH) and death. Cardiac troponin T (cTnT) and N-terminal-pro-B type natriuretic peptide (NTpBNP) are markers of cardiac function and can predict poor outcome in adults. AIMS: To determine whether echocardiography and cTnT/NTpBNP levels at 48 h predict death before discharge or severe...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Conditions and Treatments
Share to Congenital heart defects research
Share to Congenital Heart Disease Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18285375
DOI: 10.1136/adc.2007.133140

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biochemical markers may identify preterm infants with a patent ductus arteriosus at high risk of death or severe intraventricular haemorrhagePMID 18285375Read ↗

Application of NPE in the assessment of a patent ductus arteriosus.Semantic proximity Read ↗

Pulmonary Hemorrhage in Premature Infants: Pathophysiology, Risk Factors and Clinical ManagementSemantic proximity Read ↗

Updates on Management for Acute and Chronic Phenotypes of Neonatal Pulmonary Hypertension.Semantic proximity Read ↗

Clinical Phenotype of Pulmonary Vascular Disease Requiring Treatment in Extremely Preterm InfantsSemantic proximity Read ↗

Challenges, priorities and novel therapies for hypoxemic respiratory failure and pulmonary hypertension in the neonate.Semantic proximity Read ↗

Characterization of Disease Phenotype in Very Preterm Infants with Severe Bronchopulmonary Dysplasia.Semantic proximity Read ↗

Patent Ductus Arteriosus (PDA) and Response to Late Surfactant Treatment in Premature Infants Running Title: Ductus Arteriosus and Late Surfactant TreatmentSemantic proximity Read ↗

Genetics of the patent ductus arteriosus (PDA) and pharmacogenetics of PDA treatment.Semantic proximity Read ↗

Patent Ductus Arteriosus and Lung Magnetic Resonance Imaging Phenotype in Moderate and Severe Bronchopulmonary Dysplasia-Pulmonary Hypertension.Semantic proximity Read ↗

Clinical phenotype of pulmonary vascular disease requiring treatment in extremely preterm infants.Semantic proximity Read ↗

Patent arterial ductSemantic proximity Read ↗

Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.